Cargando…
Targeting phosphatidylserine for Cancer therapy: prospects and challenges
Cancer is a leading cause of mortality and morbidity worldwide. Despite major improvements in current therapeutic methods, ideal therapeutic strategies for improved tumor elimination are still lacking. Recently, immunotherapy has attracted much attention, and many immune-active agents have been appr...
Autores principales: | Chang, Wenguang, Fa, Hongge, Xiao, Dandan, Wang, Jianxun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415799/ https://www.ncbi.nlm.nih.gov/pubmed/32802188 http://dx.doi.org/10.7150/thno.45125 |
Ejemplares similares
-
MicroRNA-194-5p Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis and Endoplasmic Reticulum Stress by Targeting P21-Activated Kinase 2
por: Fa, Hongge, et al.
Publicado: (2022) -
Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer
por: Belzile, Olivier, et al.
Publicado: (2018) -
SapC-DOPS – a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy
por: N’Guessan, Kombo F., et al.
Publicado: (2020) -
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles()
por: Blanco, Victor M., et al.
Publicado: (2015) -
Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy
por: Kaynak, Ahmet, et al.
Publicado: (2022)